Astragaloside IV alleviates diabetic nephropathy by modulating the gut-kidney axis and AMPK/PI3K/AKT pathway
DOI:
10.1016/j.fbio.2024.105448
Publication Date:
2024-11-09T18:51:20Z
AUTHORS (9)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (51)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....